A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

This spontaneous mutation pattern explains why hemophilia A can appear unexpectedly in families with no known bleeding disorders. Genetic testing now allows precise identification of the specific ...

For centuries, hemophilia was a dangerous genetic disorder with no treatment. Children with hemophilia often didn't make it to adulthood, since a bump or fall could cause massive internal bleeding.

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to their critical treatment, paving the way for the development of more effective ...

China recently approved its first gene therapy for the rare genetic disorder hemophilia B, drawing renewed attention to this often-overlooked condition. Hemophilia is a rare but serious inherited ...

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...